Published in J Clin Invest on July 15, 1998
Phase and antigenic variation in bacteria. Clin Microbiol Rev (2004) 5.02
Role of microglia in central nervous system infections. Clin Microbiol Rev (2004) 2.69
Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells. Infect Immun (2005) 2.60
Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models. J Clin Invest (2009) 2.51
Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis (2010) 2.50
Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance. Infect Immun (2006) 2.15
Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. J Clin Invest (2005) 2.07
Mechanisms of microbial traversal of the blood-brain barrier. Nat Rev Microbiol (2008) 2.04
Streptococcus-zebrafish model of bacterial pathogenesis. Infect Immun (2002) 2.01
Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier. Infect Immun (2004) 1.99
Pathogenesis and pathophysiology of pneumococcal meningitis. Clin Microbiol Rev (2011) 1.87
Antibody-enhanced pneumococcal adherence requires IgA1 protease. Proc Natl Acad Sci U S A (2003) 1.81
Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae. Infect Immun (2006) 1.80
Invasion of the central nervous system by intracellular bacteria. Clin Microbiol Rev (2004) 1.71
Changes in availability of oxygen accentuate differences in capsular polysaccharide expression by phenotypic variants and clinical isolates of Streptococcus pneumoniae. Infect Immun (2001) 1.69
Interaction of Listeria monocytogenes with human brain microvascular endothelial cells: InlB-dependent invasion, long-term intracellular growth, and spread from macrophages to endothelial cells. Infect Immun (1998) 1.68
Real-time imaging of trapping and urease-dependent transmigration of Cryptococcus neoformans in mouse brain. J Clin Invest (2010) 1.67
Citrobacter freundii invades and replicates in human brain microvascular endothelial cells. Infect Immun (1999) 1.66
Iron source preference and regulation of iron uptake in Cryptococcus neoformans. PLoS Pathog (2008) 1.65
Identification of genes associated with the long-gut-persistence phenotype of the probiotic Lactobacillus johnsonii strain NCC533 using a combination of genomics and transcriptome analysis. J Bacteriol (2008) 1.62
beta-Arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae. Infect Immun (2005) 1.60
Escherichia coli translocation at the blood-brain barrier. Infect Immun (2001) 1.55
Streptococcus suis serotype 2 interactions with human brain microvascular endothelial cells. Infect Immun (2000) 1.52
The group B streptococcal serine-rich repeat 1 glycoprotein mediates penetration of the blood-brain barrier. J Infect Dis (2009) 1.52
Characterization of colony morphology variants isolated from Streptococcus pneumoniae biofilms. J Bacteriol (2006) 1.51
Identification and characterization of an Escherichia coli invasion gene locus, ibeB, required for penetration of brain microvascular endothelial cells. Infect Immun (1999) 1.51
Age-associated inflammation and toll-like receptor dysfunction prime the lungs for pneumococcal pneumonia. J Infect Dis (2009) 1.49
The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion. J Exp Med (2009) 1.48
Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by Streptococcus pneumoniae. Infect Immun (2001) 1.35
Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration. Antioxid Redox Signal (2009) 1.34
Differential protein expression in phenotypic variants of Streptococcus pneumoniae. Infect Immun (2000) 1.32
Bacterial programmed cell death of cerebral endothelial cells involves dual death pathways. J Clin Invest (2005) 1.32
Streptococcus iniae virulence is associated with a distinct genetic profile. Infect Immun (2001) 1.30
Effect of intrastrain variation in the amount of capsular polysaccharide on genetic transformation of Streptococcus pneumoniae: implications for virulence studies of encapsulated strains. Infect Immun (1999) 1.26
Contributions of pneumolysin, pneumococcal surface protein A (PspA), and PspC to pathogenicity of Streptococcus pneumoniae D39 in a mouse model. Infect Immun (2007) 1.25
Pneumococcal virulence gene expression and host cytokine profiles during pathogenesis of invasive disease. Infect Immun (2007) 1.24
The gene locus yijP contributes to Escherichia coli K1 invasion of brain microvascular endothelial cells. Infect Immun (1999) 1.24
Invasion of porcine brain microvascular endothelial cells by Streptococcus suis serotype 2. Infect Immun (2004) 1.22
Analysis of the polysaccharide capsule of the systemic pathogen Streptococcus iniae and its implications in virulence. Infect Immun (2006) 1.17
Escherichia coli binding to and invasion of brain microvascular endothelial cells derived from humans and rats of different ages. Infect Immun (1999) 1.14
Neisseria meningitidis induces brain microvascular endothelial cell detachment from the matrix and cleavage of occludin: a role for MMP-8. PLoS Pathog (2010) 1.11
Science review: The brain in sepsis--culprit and victim. Crit Care (2004) 1.11
Decoration of Pasteurella multocida lipopolysaccharide with phosphocholine is important for virulence. J Bacteriol (2007) 1.09
Pneumolysin-dependent and -independent gene expression identified by cDNA microarray analysis of THP-1 human mononuclear cells stimulated by Streptococcus pneumoniae. Infect Immun (2003) 1.08
Contribution of lethal toxin and edema toxin to the pathogenesis of anthrax meningitis. Infect Immun (2011) 1.06
Phenotypic switching in a Cryptococcus neoformans variety gattii strain is associated with changes in virulence and promotes dissemination to the central nervous system. Infect Immun (2006) 1.05
Non-typeable Haemophilus influenzae invasion and persistence in the human respiratory tract. Front Cell Infect Microbiol (2011) 1.05
Pathogens penetrating the central nervous system: infection pathways and the cellular and molecular mechanisms of invasion. Clin Microbiol Rev (2014) 1.03
Invasion of human vascular endothelial cells by Actinobacillus actinomycetemcomitans via the receptor for platelet-activating factor. Infect Immun (2000) 1.03
Differential activation of the immune system by virulent Streptococcus pneumoniae strains determines recovery or death of the host. Clin Exp Immunol (2003) 1.02
Hypoxia-inducible factor-dependent regulation of platelet-activating factor receptor as a route for gram-positive bacterial translocation across epithelia. Mol Biol Cell (2009) 1.01
The role of pneumolysin in mediating lung damage in a lethal pneumococcal pneumonia murine model. Respir Res (2007) 1.00
In vivo demonstration and quantification of intracellular Bacillus anthracis in lung epithelial cells. Infect Immun (2008) 0.99
Penetration of the blood-brain barrier by Staphylococcus aureus: contribution of membrane-anchored lipoteichoic acid. J Mol Med (Berl) (2010) 0.99
Pathophysiology and treatment of bacterial meningitis. Ther Adv Neurol Disord (2009) 0.98
Activation of brain endothelium by pneumococcal neuraminidase NanA promotes bacterial internalization. Cell Microbiol (2010) 0.98
Carbonic anhydrase is essential for Streptococcus pneumoniae growth in environmental ambient air. J Bacteriol (2010) 0.97
Citrobacter koseri brain abscess in the neonatal rat: survival and replication within human and rat macrophages. Infect Immun (2003) 0.97
Understanding the pneumococcus: transmission and evolution. Front Cell Infect Microbiol (2013) 0.94
Pneumococcal meningitis: development of a new animal model. Otol Neurotol (2006) 0.94
Streptococcus pneumoniae causes experimental meningitis following intranasal and otitis media infections via a nonhematogenous route. Infect Immun (2001) 0.94
Translocation of Enterococcus faecalis strains across a monolayer of polarized human enterocyte-like T84 cells. J Clin Microbiol (2004) 0.93
Polyvalent choline phosphate as a universal biomembrane adhesive. Nat Mater (2012) 0.92
Penetration of the blood-brain barrier by Bacillus anthracis requires the pXO1-encoded BslA protein. J Bacteriol (2009) 0.91
Pneumococci in biofilms are non-invasive: implications on nasopharyngeal colonization. Front Cell Infect Microbiol (2014) 0.90
The platelet activating factor receptor is not required for exacerbation of bacterial pneumonia following influenza. Scand J Infect Dis (2007) 0.90
The human polymeric immunoglobulin receptor facilitates invasion of epithelial cells by Streptococcus pneumoniae in a strain-specific and cell type-specific manner. Infect Immun (2002) 0.90
Pathogenesis of meningococcemia. Cold Spring Harb Perspect Med (2013) 0.90
Platelet-activating factor receptor initiates contact of Acinetobacter baumannii expressing phosphorylcholine with host cells. J Biol Chem (2012) 0.89
Characterization of a new mouse model of empyema and the mechanisms of pleural invasion by Streptococcus pneumoniae. Am J Respir Cell Mol Biol (2011) 0.89
Mechanism of meningeal invasion by Neisseria meningitidis. Virulence (2012) 0.89
The lack of Pneumococcal surface protein C (PspC) increases the susceptibility of Streptococcus pneumoniae to the killing by microglia. Med Microbiol Immunol (2005) 0.88
Endothelial cells are a replicative niche for entry of Toxoplasma gondii to the central nervous system. Nat Microbiol (2016) 0.88
Interactions between blood-borne Streptococcus pneumoniae and the blood-brain barrier preceding meningitis. PLoS One (2013) 0.88
Streptococcus pneumoniae invades endothelial host cells via multiple pathways and is killed in a lysosome dependent manner. PLoS One (2013) 0.88
NADH oxidase functions as an adhesin in Streptococcus pneumoniae and elicits a protective immune response in mice. PLoS One (2013) 0.87
Defense at the border: the blood-brain barrier versus bacterial foreigners. Future Microbiol (2012) 0.86
A monoclonal antibody that conveys in vitro killing and partial protection in experimental syphilis binds a phosphorylcholine surface epitope of Treponema pallidum. Infect Immun (2005) 0.86
Genetic variation in the β2-adrenocepter gene is associated with susceptibility to bacterial meningitis in adults. PLoS One (2012) 0.86
Interaction of pneumococcal phase variation and middle ear pressure/gas composition: an in vitro model of simulated otitis media. Microb Pathog (2008) 0.85
Characterization of the invasion of porcine endothelial cells by Streptococcus suis serotype 2. Can J Vet Res (2007) 0.84
Concepts and mechanisms: crossing host barriers. Cold Spring Harb Perspect Med (2013) 0.83
Immune responses to non-tumor antigens in the central nervous system. Front Oncol (2014) 0.83
Cigarette Smoke Attenuates the Nasal Host Response to Streptococcus pneumoniae and Predisposes to Invasive Pneumococcal Disease in Mice. Infect Immun (2016) 0.83
Lipoteichoic acid-induced nitric oxide production depends on the activation of platelet-activating factor receptor and Jak2. J Immunol (2006) 0.82
Toxoplasma gondii and the blood-brain barrier. Virulence (2012) 0.82
Contribution of different pneumococcal virulence factors to experimental meningitis in mice. BMC Infect Dis (2013) 0.82
Streptococcus pneumoniae Interacts with pIgR expressed by the brain microvascular endothelium but does not co-localize with PAF receptor. PLoS One (2014) 0.82
Increased anisotropy in neonatal meningitis: an indicator of meningeal inflammation. Neuroradiology (2007) 0.82
Host-pathogen interactions in bacterial meningitis. Acta Neuropathol (2016) 0.82
Platelet endothelial cell adhesion molecule-1, a putative receptor for the adhesion of Streptococcus pneumoniae to the vascular endothelium of the blood-brain barrier. Infect Immun (2014) 0.81
Arrestins in host-pathogen interactions. Handb Exp Pharmacol (2014) 0.80
Oxidative stress and S-100B protein in children with bacterial meningitis. BMC Neurol (2009) 0.79
Anatomical site-specific contributions of pneumococcal virulence determinants. Pneumonia (Nathan) (2016) 0.79
Inflammasome/IL-1β Responses to Streptococcal Pathogens. Front Immunol (2015) 0.78
Next generation of non-mammalian blood-brain barrier models to study parasitic infections of the central nervous system. Virulence (2012) 0.77
Comparative Genomic Analysis of Meningitis- and Bacteremia-Causing Pneumococci Identifies a Common Core Genome. Infect Immun (2015) 0.77
The proteasome-ubiquitin system is required for efficient killing of intracellular Streptococcus pneumoniae by brain endothelial cells. MBio (2014) 0.77
Anchors away: contribution of a glycolipid anchor to bacterial invasion of host cells. J Clin Invest (2005) 0.77
Differential transcription profiles of long non-coding RNAs in primary human brain microvascular endothelial cells in response to meningitic Escherichia coli. Sci Rep (2016) 0.76
A study of the genetic material determining an enzyme in Pneumococcus. Biochim Biophys Acta (1960) 16.02
A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12. Nature (1985) 9.45
Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature (1995) 5.15
Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect Immun (1994) 4.90
Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Mol Microbiol (1997) 4.78
Bacillus subtilis expressing a haemolysin gene from Listeria monocytogenes can grow in mammalian cells. Nature (1990) 4.58
Porphyromonas gingivalis invasion of gingival epithelial cells. Infect Immun (1995) 4.33
Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J Infect Dis (1998) 4.12
Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAc beta 1-4Gal found in some glycolipids. Proc Natl Acad Sci U S A (1988) 3.83
Outer membrane protein A of Escherichia coli contributes to invasion of brain microvascular endothelial cells. Infect Immun (1996) 3.53
Isolation of transformation-deficient Streptococcus pneumoniae mutants defective in control of competence, using insertion-duplication mutagenesis with the erythromycin resistance determinant of pAM beta 1. J Bacteriol (1984) 3.10
Invasion of brain microvascular endothelial cells by group B streptococci. Infect Immun (1997) 2.97
Escherichia coli invasion of brain microvascular endothelial cells in vitro and in vivo: molecular cloning and characterization of invasion gene ibe10. Infect Immun (1995) 2.91
Relationship between colonial morphology and adherence of Streptococcus pneumoniae. Infect Immun (1995) 2.50
Adhesion of Streptococcus pneumoniae to human pharyngeal epithelial cells in vitro: differences in adhesive capacity among strains isolated from subjects with otitis media, septicemia, or meningitis or from healthy carriers. Infect Immun (1981) 2.33
Binding characteristics of S fimbriated Escherichia coli to isolated brain microvascular endothelial cells. Am J Pathol (1994) 2.21
The cell wall mediates pneumococcal attachment to and cytopathology in human endothelial cells. Infect Immun (1993) 2.09
Group B streptococci invade endothelial cells: type III capsular polysaccharide attenuates invasion. Infect Immun (1993) 2.01
Uptake of Streptococcus pneumoniae by respiratory epithelial cells. Infect Immun (1996) 2.01
Defining lipid transport pathways in animal cells. Science (1985) 2.00
Relationship between phase variation in colony morphology, intrastrain variation in cell wall physiology, and nasopharyngeal colonization by Streptococcus pneumoniae. Infect Immun (1996) 1.85
Morphologic alterations of the blood-brain barrier with experimental meningitis in the rat. Temporal sequence and role of encapsulation. J Clin Invest (1986) 1.63
Effect of type III group B streptococcal capsular polysaccharide on invasion of respiratory epithelial cells. Infect Immun (1993) 1.63
Cytotoxic effects of ingested Staphylococcus aureus on bovine endothelial cells: role of S. aureus alpha-hemolysin. Microb Pathog (1988) 1.46
Accelerated neutrophil apoptosis in the acquired immunodeficiency syndrome. J Clin Invest (1996) 1.30
Differing roles for platelet-activating factor during inflammation of the lung and subarachnoid space. The special case of Streptococcus pneumoniae. J Clin Invest (1992) 1.27
A tissue culture bilayer model to study the passage of Neisseria meningitidis. Infect Immun (1995) 1.16
Cloning, expression and tissue distribution of rat platelet-activating-factor-receptor cDNA. Eur J Biochem (1994) 1.11
(+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonist. Biochem Biophys Res Commun (1988) 1.07
The biology of pneumococcal infection. Pediatr Res (1997) 1.06
Cell type-specific tumor induction in neural transplants by retrovirus-mediated oncogene transfer. Oncogene (1991) 0.95
BN 52021 displaces [3H]paf-acether from, and inhibits its binding to intact human platelets. Eur J Pharmacol (1987) 0.91
Penetration of the blood-brain barrier: enhancement of drug delivery and imaging by bacterial glycopeptides. J Exp Med (1995) 0.89
Dexamethasone selectively regulates the activity of enzymatic markers of cerebral endothelial cell lines. In Vitro Cell Dev Biol (1992) 0.85
Polarized epithelial monolayers: model systems to study bacterial interactions with host epithelial cells. Methods Enzymol (1994) 0.84
Receptor-dependent internalization of platelet-activating factor. J Immunol (1994) 0.83
Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell (1995) 7.55
Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature (1995) 5.15
Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Mol Microbiol (1997) 4.78
Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J Infect Dis (1998) 4.12
Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. Lancet (2004) 3.54
Outer membrane protein A of Escherichia coli contributes to invasion of brain microvascular endothelial cells. Infect Immun (1996) 3.53
The murein hydrolases of Escherichia coli: properties, functions and impact on the course of infections in vivo. J Gen Microbiol (1991) 3.09
Inhibitory and bactericidal effects of hydrogen peroxide production by Streptococcus pneumoniae on other inhabitants of the upper respiratory tract. Infect Immun (2000) 2.91
Role of novel choline binding proteins in virulence of Streptococcus pneumoniae. Infect Immun (2000) 2.75
Non-typeable Haemophilus influenzae adhere to and invade human bronchial epithelial cells via an interaction of lipooligosaccharide with the PAF receptor. Mol Microbiol (2000) 2.65
Relationship between colonial morphology and adherence of Streptococcus pneumoniae. Infect Immun (1995) 2.50
Relationship between cell surface carbohydrates and intrastrain variation on opsonophagocytosis of Streptococcus pneumoniae. Infect Immun (1999) 2.20
Microarray-based identification of htrA, a Streptococcus pneumoniae gene that is regulated by the CiaRH two-component system and contributes to nasopharyngeal colonization. Infect Immun (2002) 1.87
Relationship between phase variation in colony morphology, intrastrain variation in cell wall physiology, and nasopharyngeal colonization by Streptococcus pneumoniae. Infect Immun (1996) 1.85
Bacterial phosphorylcholine decreases susceptibility to the antimicrobial peptide LL-37/hCAP18 expressed in the upper respiratory tract. Infect Immun (2000) 1.84
Molecular pathogenesis of pneumococcal pneumonia. Front Biosci (2001) 1.82
Consequences of microbial attachment: directing host cell functions with adhesins. Infect Immun (1992) 1.79
Receptor specificity of adherence of Streptococcus pneumoniae to human type-II pneumocytes and vascular endothelial cells in vitro. Microb Pathog (1994) 1.71
Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nat Med (1999) 1.71
The position of phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae affects binding and sensitivity to C-reactive protein-mediated killing. Mol Microbiol (2000) 1.70
Binding of the non-typeable Haemophilus influenzae lipooligosaccharide to the PAF receptor initiates host cell signalling. Cell Microbiol (2001) 1.68
Pneumococcal licD2 gene is involved in phosphorylcholine metabolism. Mol Microbiol (1999) 1.68
Identification, cloning, and sequencing of the immunoglobulin A1 protease gene of Streptococcus pneumoniae. Infect Immun (1996) 1.60
Pertussis toxin has eukaryotic-like carbohydrate recognition domains. Proc Natl Acad Sci U S A (1992) 1.56
Adherence of Bordetella pertussis to human respiratory epithelial cells. J Infect Dis (1983) 1.54
Identification of a carbohydrate recognition domain in filamentous hemagglutinin from Bordetella pertussis. Infect Immun (1993) 1.42
The genetic basis of colony opacity in Streptococcus pneumoniae: evidence for the effect of box elements on the frequency of phenotypic variation. Mol Microbiol (1995) 1.39
Species specificity of Bordetella adherence to human and animal ciliated respiratory epithelial cells. Infect Immun (1983) 1.36
Oral chloramphenicol in the treatment of Haemophilus influenzae meningitis. J Pediatr (1981) 1.33
Differential protein expression in phenotypic variants of Streptococcus pneumoniae. Infect Immun (2000) 1.32
Expression of C-reactive protein in the human respiratory tract. Infect Immun (2001) 1.31
Apoptosis-inducing factor mediates microglial and neuronal apoptosis caused by pneumococcus. J Infect Dis (2001) 1.30
Effect of influenza A virus infection on nasopharyngeal colonization and otitis media induced by transparent or opaque phenotype variants of Streptococcus pneumoniae in the chinchilla model. Infect Immun (2001) 1.30
Antigenic similarities in lipopolysaccharides of Haemophilus and Neisseria and expression of a digalactoside structure also present on human cells. Microb Pathog (1990) 1.30
The concentration-dependent membrane activity of cecropin A. Biochemistry (1997) 1.29
Adherence of Streptococcus pneumoniae to immobilized fibronectin. Infect Immun (1995) 1.27
Role of carbohydrate recognition domains of pertussis toxin in adherence of Bordetella pertussis to human macrophages. Infect Immun (1992) 1.24
Neural targeting of Mycobacterium leprae mediated by the G domain of the laminin-alpha2 chain. Cell (1997) 1.19
Pneumococcal HtrA protease mediates inhibition of competence by the CiaRH two-component signaling system. J Bacteriol (2005) 1.15
Characterization of antibody inhibiting adherence of Bordetella pertussis to human respiratory epithelial cells. J Clin Microbiol (1984) 1.15
The molecular basis of pneumococcal infection: a hypothesis. Clin Infect Dis (1995) 1.14
Antibacterial and antimembrane activities of cecropin A in Escherichia coli. Antimicrob Agents Chemother (2000) 1.13
Structural studies of the saccharide part of the cell envelope lipopolysaccharide from Haemophilus influenzae strain AH1-3 (lic3+). Carbohydr Res (1993) 1.07
The transfer of choline from the host to the bacterial cell surface requires glpQ in Haemophilus influenzae. Mol Microbiol (2001) 1.07
PAf receptor anchors Streptococcus pneumoniae to activated human endothelial cells. Adv Exp Med Biol (1996) 1.04
Opacity-associated protein A contributes to the binding of Haemophilus influenzae to chang epithelial cells. Infect Immun (1999) 1.03
Transposon mutagenesis of group B streptococcus beta-hemolysin biosynthesis. Infect Immun (1987) 0.97
Reprogramming the host response in bacterial meningitis: how best to improve outcome? Clin Microbiol Rev (2003) 0.95
Composition of the peptidoglycan of Haemophilus influenzae. J Biol Chem (1993) 0.95
The role of N-glycosylation for functional expression of the human platelet-activating factor receptor. Glycosylation is required for efficient membrane trafficking. J Biol Chem (1995) 0.93
Antigenic diversity of Haemophilus somnus lipooligosaccharide: phase-variable accessibility of the phosphorylcholine epitope. J Clin Microbiol (2000) 0.91
Characterization of the phosphocholine-substituted oligosaccharide in lipopolysaccharides of type b Haemophilus influenzae. Eur J Biochem (2000) 0.89
Molecular analysis of two group B streptococcal virulence factors. Semin Perinatol (1990) 0.89
Glucocorticoid and estrogen regulation of corticosteroid-binding globulin production by rat liver. Am J Physiol (1979) 0.87
Staphylococcal protein A adsorption of neonatal serum to facilitate early diagnosis of congenital infection. J Pediatr (1980) 0.87
The pathophysiology of pneumococcal meningitis. Ann Med (1994) 0.86
Role of lipopolysaccharide phase variation in susceptibility of Haemophilus influenzae to bactericidal immunoglobulin M antibodies in rabbit sera. Infect Immun (2000) 0.82
Cerebral cell adhesion molecule: a novel leukocyte adhesion determinant on blood-brain barrier capillary endothelium. J Infect Dis (2000) 0.81
Molecular mechanisms of brain damage in bacterial meningitis. Adv Pediatr Infect Dis (1999) 0.81
Pneumococcal cell wall activates NF-kappa B in human monocytes: aspects distinct from endotoxin. Microb Pathog (1996) 0.81
Synthesis and secretion of corticosteroid-binding globulin by rat liver. A source of heterogeneity of hepatic corticosteroid-binders. J Clin Invest (1979) 0.80
Host cell invasion by Streptococcus pneumoniae. Subcell Biochem (2000) 0.79
Surprise? Bacteria glycosylate proteins too. J Clin Invest (1996) 0.79
Recurrent pneumococcal bacteremia in normal children. Pediatr Infect Dis J (1994) 0.75
Radionuclide joint imaging: acute rheumatic fever simulating septic arthritis. Pediatrics (1980) 0.75
Recombinant microbial ADP-ribosylating toxins of Bordetella pertussis, Vibrio cholerae, and enterotoxigenic Escherichia coli: structure, function, and toxoid vaccine development. Bioprocess Technol (1994) 0.75